JUBILIANT PHARMOVA BREAKOUT AFTER 6 YEARS
The stock has been in consolidation phase since january 2018 and could not breach 888 and 1039 resistance respectively however lately the stock has smashed both of them and rallied to an unstoppable territory
The volumes also indicate pretty good buying also DIIs have increased their holdings in the stock
The company formed cup and handle in 2019 but failed badly nevertheless the stock rebounded pretty well and gave a pretty goood breakout lately
The company has more than 132 patents and is engaged in pharmaceuticals , contract research and development services
TARGET - 1800
The volumes also indicate pretty good buying also DIIs have increased their holdings in the stock
The company formed cup and handle in 2019 but failed badly nevertheless the stock rebounded pretty well and gave a pretty goood breakout lately
The company has more than 132 patents and is engaged in pharmaceuticals , contract research and development services
TARGET - 1800
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.